For example, mood stabilizer valproic acid and chiral isomer valnoctamide have been shown to take effect in the treatment of bipolar disorder by inhibiting recombinant ACSL4, brain AA turnover in brain phospholipids, and AA activation to AA-CoA (Modi et al., 2014, 2017). This evidence concerns the gene ACSL4 and bipolar disorder.